The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

6 Aug 2019 17:13

RNS Number : 1523I
JPMorgan Elect PLC
06 August 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN ELECT PLC

('the Company')

 

REPURCHASE OF SHARES

 

 

Legal Entity Identifier: 549300FIUYKKL39ILD07

 

 

 

Managed Growth

The Company has today purchased 21,750 Managed Growth shares into Treasury at 828.96 pence per share.

 

Following the transaction the Company holds 7,402,675 Managed Growth shares in Treasury. The remaining Managed Growth shares in issue less the total number of Managed Growth shares in Treasury is 30,962,015.

 

The Company will only re-issue shares held in Treasury at a premium to net asset value.

 

Managed Income

The Company has today purchased 25,108 Managed Income shares into Treasury at 101.97 pence per share.

 

Following the transaction the Company holds 11,969,125 Managed Income shares in Treasury. The remaining Managed Income shares in issue less the total number of Managed Income shares in Treasury is 86,496,349.

 

The Company will only re-issue shares held in Treasury at a premium to net asset value.

 

 

 

06 August 2019

 

For further information, please contact:

 

Faith Pengelly

JPMorgan Funds Limited - Secretary

Telephone 020 7742 4000

 

Julian Dixon

Winterflood Securities - Stockbrokers to the Company

020 3100 0253

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSSSSFMMFUSEFA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.